Are patients worried about muscle loss from GLP-1 agonists?

Reviewed by Yoshinori Abe, MD

Internal Medicine

GLP-1 agonists like Ozempic and Wegovy can cause some muscle loss alongside fat loss, but research shows mixed results. Some studies indicate lean mass reduction is proportional to overall weight loss and comparable to other weight-loss methods, while others suggest muscle preservation strategies—like resistance training and adequate protein intake—can significantly reduce this risk.

If you're experiencing unexplained weakness, fatigue, or other symptoms while on a GLP-1 medication, it's important to understand what's driving them. Muscle loss, nutritional deficiencies, or unrelated conditions could all be at play—and pinpointing the cause is the first step toward addressing it. Take a free, instant, online symptom check to better understand your health and confidently plan your next steps.

Reviewed for medical accuracy: 07/20/2026

Important Next Steps

Discover what's causing your muscle loss Learn if muscle loss needs urgent care Find out if muscle loss is serious See OTC options for muscle loss Find a doctor for muscle loss Discover home remedies for muscle loss Understand if muscle loss could be dangerous

Not seeing your question? No worries.

Submit your own Question

Explanation

GLP-1 agonists are medications often used for weight loss and diabetes management. Some patients are worried that these drugs might cause them to lose muscle mass, not just fat.

Here are some insights from recent studies:

Lean Body Mass Changes: According to a study in 'Diabetes, Obesity & Metabolism', changes in lean body mass can occur with GLP-1 agonist use, but the overall impact varies among individuals.
Overall Impact: Another study in 'Current Nutrition Reports' suggests that while there might be some lean mass loss, the benefits of weight loss and improved metabolic health often outweigh these concerns for many patients.
Muscle Mass Considerations: Research in 'Circulation' indicates that while there may be changes in muscle mass, the clinical significance is not fully clear, and more research is needed.

In summary, while there is some evidence of muscle loss in certain cases, the overall benefits of GLP-1 agonists in managing weight and diabetes are significant. If you're experiencing unusual symptoms or have concerns about how these medications might be affecting your body, try our free AI symptom checker to better understand your health situation, then discuss the results with your healthcare provider.

(References)

Neeland IJ, Linge J, & Birkenfeld AL. (2024). Changes in lean body mass with glucagon-like peptide-1- .... Diabetes, obesity & metabolism, 38937282.
Memel Z, Gold SL, Pearlman M, Muratore A, & Martindale R. (2025). Impact of GLP- 1 Receptor Agonist Therapy in Patients .... Current nutrition reports, 40289060.
Linge J, Birkenfeld AL, & Neeland IJ. (2024). Muscle Mass and Glucagon-Like Peptide-1 Receptor .... Circulation, 39401279.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.